Latest news

Daily Snap - 24. September 2025

Daily Snap - 24. September 2025

Joachim Eeckhout
FDA rejects Scholar Rock’s SMA drug over manufacturing issues

FDA rejects Scholar Rock’s SMA drug over manufacturing issues

Eduardo Longoria
FDA pushes GSK to revive old cancer drug for rare autism-linked disorder

FDA pushes GSK to revive old cancer drug for rare autism-linked disorder

Eduardo Longoria
Daily Snap - 23. September 2025

Daily Snap - 23. September 2025

Joachim Eeckhout
Angelini Pharma strikes $550M+ deal to boost brain health drug pipeline

Angelini Pharma strikes $550M+ deal to boost brain health drug pipeline

Eduardo Longoria
Pfizer bets $4.9B on Metsera to rejoin the obesity drug race

Pfizer bets $4.9B on Metsera to rejoin the obesity drug race

Eduardo Longoria
Daily Snap - 22. September 2025

Daily Snap - 22. September 2025

Joachim Eeckhout
Novo Nordisk’s once-weekly diabetes combo drug wins EU support after U.S. setback

Novo Nordisk’s once-weekly diabetes combo drug wins EU support after U.S. setback

Eduardo Longoria
FDA greenlights first-ever Barth syndrome drug after decade-long push

FDA greenlights first-ever Barth syndrome drug after decade-long push

Eduardo Longoria
Daily Snap - 19. September 2025

Daily Snap - 19. September 2025

Joachim Eeckhout
VectorY inks $1.2B deal to boost brain-targeted gene therapy with Shape's delivery tech

VectorY inks $1.2B deal to boost brain-targeted gene therapy with Shape's delivery tech

Eduardo Longoria
Roche bets $2.4B on potential MASH breakthrough with 89bio buy

Roche bets $2.4B on potential MASH breakthrough with 89bio buy

Eduardo Longoria
FirstBack
56789101112
Next Last